Endometrial Adenosquamous Carcinoma
Showing 1 - 9 of 9
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States
Active, not recruiting
- Endometrial Adenocarcinoma
- +9 more
- Bevacizumab
- +5 more
-
Phoenix, Arizona
- +232 more
Jan 12, 2023
Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,
Recruiting
- Cervical Adenocarcinoma
- +47 more
- Bevacizumab
- +3 more
-
Phoenix, Arizona
- +3 more
Dec 5, 2022
Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma Trial in
Active, not recruiting
- Endometrial Adenosquamous Carcinoma
- +9 more
- Cabozantinib S-malate
- +2 more
-
Duarte, California
- +18 more
Oct 15, 2022
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States
Completed
- Endometrial Adenocarcinoma
- +4 more
- Akt Inhibitor MK2206
- Laboratory Biomarker Analysis
-
Boston, Massachusetts
- +6 more
Jan 13, 2022
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States
Completed
- Endometrial Adenocarcinoma
- +3 more
- Diagnostic Laboratory Biomarker Analysis
- Selumetinib
-
Los Angeles, California
- +71 more
Jul 19, 2019
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in Canada, Hong
Completed
- Endometrial Adenocarcinoma
- +11 more
- Bevacizumab
- +4 more
-
Berkeley, California
- +40 more
Feb 15, 2018
Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma Trial in United
Completed
- Endometrial Adenosquamous Carcinoma
- +10 more
- Cisplatin
- +4 more
-
Hartford, Connecticut
- +8 more
Aug 23, 2017
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Endometrioid Adenocarcinoma, Variant With Squamous
Completed
- Endometrial Adenocarcinoma
- +7 more
- Laboratory Biomarker Analysis
- +2 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Mar 17, 2016
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in Philadelphia
Completed
- Endometrial Adenocarcinoma
- +5 more
- Doxorubicin Hydrochloride
- +4 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Apr 30, 2015